Super Micro Computer has shed another 28% this week to $29.22 — extending a brutal run that has now erased roughly 45% of the stock's value in 2026 — and the options market, which called the last leg down, is flashing its most defensive reading of the year.
The clearest signal this week is in options positioning. The put/call ratio jumped to 0.81 on Tuesday, more than 2.4 standard deviations above its 20-day average of 0.73 — just below the 52-week high of 0.89 hit during the prior selloff. That's the most defensive options posture since the last note flagged the 0.88 reading as a warning. At that point the stock was at $40.64. It's now at $29.22. The borrow market, however, continues to tell a contrarian story: cost to borrow has actually fallen 37% on the week to just 0.46%, near its lowest level of the past 30 days. Availability remains loose at 160% of short interest — tight relative to the 256% reading from a week ago, but well above the 52-week floor of 85%. There is no squeeze setup here. The lending market is tightening incrementally alongside the price decline, but nowhere near levels that would pressure the short side.
Short interest has been remarkably stable through the carnage. It edged up just under 2% on the week to 13.3% of free float — roughly 79 million shares — and has barely moved from month-ago levels of around 13.0%. That persistence confirms what the prior note described: short conviction on SMCI is structural, not reactive. Shorts added modestly into the May earnings rally, held through it, and are still there as the stock gives it all back. Days to cover runs at 1.69, tight enough that shorts aren't particularly trapped, but the ORTEX short score ticking to 62.2 — its highest reading of the past ten days — reflects the overall bearish configuration.
The Street is in a holding pattern, with the consensus firmly at Hold and no major upgrades in recent weeks. Wolfe Research initiated at Peer Perform on June 11. Mizuho raised its target to $44 on June 1, maintaining Neutral. JPMorgan is sitting at Neutral with a $32 target — essentially at the current price. The range of targets from the May 6 post-earnings flurry ($31–$40) now mostly sits above where the stock trades, which is a mechanical positive on paper, but the analyst community has shown little appetite to step up conviction. The EV/EBITDA multiple has compressed to 6.7x, down half a turn in 30 days, while the PE of 10.2x sits near year-lows. ORTEX factor scores underline the split personality: EV/EBIT ranks in the 84th percentile of the universe — genuinely cheap — but the short score rank is in the bottom 5th percentile, and momentum is the worst pillar in the stock's composite score.
The institutional ownership picture adds texture. Founder Charles Liang trimmed 340,000 shares in the most recent filing, and co-founder Chiu-Chu Liu Liang sold a further 337,000 shares. The amounts are modest relative to their combined 10%+ stake, but the direction matters given where the stock is trading. BlackRock added 1.7 million shares in May, and UBS Asset Management built a nearly 5 million share position. Marshall Wace — which tends to move with more tactical intent — initiated a 7.1 million share position in Q1. That's a meaningful new long from a firm not known for passive accumulation.
Against close peers, SMCI's week stands out sharply. WDC gained 32% and STX rose 22% over the same period — both storage names catching a different sector tailwind. DELL added nearly 6%. SMCI's divergence from the hardware peer group is widening, not narrowing. Earnings are next scheduled for August 4. The prior print on May 5 delivered a 24% one-day gain and a 17% five-day move — a reminder that the stock remains capable of violent reversals in either direction. With the August date confirmed, what to watch is whether the current PCR level — sitting near its 52-week peak — holds, eases, or pushes higher into that reporting window.
See the live data behind this article on ORTEX.
Open SMCI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
